Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johanna Westra

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Molecular Medicine (Cambridge, Mass.)|February 18, 2014
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosusFleur Schaper, Johanna Westra, Marc Bijl
Autoimmunity Reviews|April 26, 2011
Dysregulated neutrophil--endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease interventionNan Hu, Johanna Westra, Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Autoimmunity Reviews|February 3, 2009
Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's GranulomatosisNan Hu, Johanna Westra, Cees G M Kallenberg
Current Medicinal Chemistry|March 11, 2010
Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implicationsJohanna Westra, Grietje Molema, C G M Kallenberg
Nature Reviews. Rheumatology|December 10, 2014
Vaccination of patients with autoimmune inflammatory rheumatic diseasesJohanna Westra, Christien Rondaan, Sander van Assen, et al.
Seminars in Arthritis and Rheumatism|December 28, 2020
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markersWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Antioxidants (Basel, Switzerland)|October 26, 2024
The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus ErythematosusLu Liu, Karina de Leeuw, Harry van Goor, et al.
The Journal of Rheumatology|November 16, 2020
Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus ErythematosusWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Arthritis Care & Research|September 25, 2020
ReplyWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Molecular Medicine (Cambridge, Mass.)|February 18, 2014
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosusFleur Schaper, Johanna Westra, Marc Bijl
Autoimmunity Reviews|April 26, 2011
Dysregulated neutrophil--endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease interventionNan Hu, Johanna Westra, Cees G M Kallenberg
Current Opinion in Rheumatology|December 20, 2012
Inhibition of high-mobility group box 1 as therapeutic option in autoimmune disease: lessons from animal modelsFleur Schaper, Peter Heeringa, Marc Bijl, et al.
Autoimmunity Reviews|February 3, 2009
Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's GranulomatosisNan Hu, Johanna Westra, Cees G M Kallenberg
Current Medicinal Chemistry|March 11, 2010
Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implicationsJohanna Westra, Grietje Molema, C G M Kallenberg
Nature Reviews. Rheumatology|December 10, 2014
Vaccination of patients with autoimmune inflammatory rheumatic diseasesJohanna Westra, Christien Rondaan, Sander van Assen, et al.
Seminars in Arthritis and Rheumatism|December 28, 2020
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markersWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Antioxidants (Basel, Switzerland)|October 26, 2024
The Role of Antioxidant Transcription Factor Nrf2 and Its Activating Compounds in Systemic Lupus ErythematosusLu Liu, Karina de Leeuw, Harry van Goor, et al.
The Journal of Rheumatology|November 16, 2020
Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus ErythematosusWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Arthritis Care & Research|September 25, 2020
ReplyWietske M Lambers, Johanna Westra, Hendrika Bootsma, et al.
Pageof 12